(Reuters) - Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted an about 3 percent fall in quarterly profit, missing estimates, hurt by headwinds in the U.S. market.
Profit for the quarter ended March 31 came in at 3.02 billion rupees ($44.40 million) versus 3.13 billion rupees a year earlier, the company said https://www.bseindia.com/xml-data/corpfiling/AttachLive/280bdd33-dda4-4c5f-8624-b01b7efaeb68.pdf.
Analysts on average estimated a profit of 3.59 billion rupees, according to Thomson Reuters data.
Revenue fell slightly to 35.35 billion rupees.
($1 = 68.0175 Indian rupees)
(Reporting By Arnab Paul in Bengaluru; Editing by Biju Dwarakanath)
Disclaimer: No Business Standard Journalist was involved in creation of this content
